Long-term survival and safety of elranatamab in patients with relapsed or refractory multiple myeloma: Update from the MagnetisMM-3 study Research Letter

   

Authors:	Tomasson, M. H.; Iida, S.; Niesvizky, R.; Mohty, M.; Bahlis, N. J.; Martinez-Lopez, J.; Koehne, G.; Rodriguez-Otero, P.; Miles Prince, H.; Viqueira, A.; Leip, E.; Conte, U.; Sullivan, S. T.; Lesokhin, A. M.
Title:	Long-term survival and safety of elranatamab in patients with relapsed or refractory multiple myeloma: Update from the MagnetisMM-3 study
Journal Title:	HemaSphere
Volume:	8
Issue:	7
ISSN:	2572-9241
Publisher:	Lippincott Williams & Wilkins
Date Published:	2024-07-01
Start Page:	e136
Language:	English
DOI:	10.1002/hem3.136
PROVIDER:	scopus
PMCID:	PMC11269363
PUBMED:	39055646
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85199443925&doi=10.1002%2fhem3.136&partnerID=40&md5=864b7423517896870346c65ad0f6d5be
Notes:	Letter -- MSK corresponding author is Alexander Lesokhin -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/217493